These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1698579)

  • 1. Relation between the increase of circulating CD3+ CD57+ lymphocytes and T cell dysfunction in recipients of bone marrow transplantation.
    Izquierdo M; Balboa MA; Fernández-Rañada JM; Figuera A; Torres A; Iriondo A; López-Botet M
    Clin Exp Immunol; 1990 Oct; 82(1):145-50. PubMed ID: 1698579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defective interleukin 2 receptor expression is associated with the T cell disfunction subsequent to bone marrow transplantation.
    López-Botet M; De Landazuri MO; Izquierdo M; Ramirez A; Cámara R; Fernández-Rañada J
    Eur J Immunol; 1987 Aug; 17(8):1167-74. PubMed ID: 3113980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of CD8+CD57+ T cells after allogeneic BMT is related with a low incidence of relapse and with cytomegalovirus infection.
    Dolstra H; Preijers F; Van de Wiel-van Kemenade E; Schattenberg A; Galama J; de Witte T
    Br J Haematol; 1995 Jun; 90(2):300-7. PubMed ID: 7540855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reconstitution of T-cell function after CD6-depleted allogeneic bone marrow transplantation.
    Soiffer RJ; Bosserman L; Murray C; Cochran K; Daley J; Ritz J
    Blood; 1990 May; 75(10):2076-84. PubMed ID: 1970938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow.
    Welte K; Keever CA; Levick J; Bonilla MA; Merluzzi VJ; Mertelsmann R; Evans R; O'Reilly RJ
    Blood; 1987 Nov; 70(5):1595-603. PubMed ID: 3311208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphokine production by T-cell clones after human bone marrow transplantation.
    Velardi A; Varese P; Terenzi A; Dembech C; Albi N; Grossi CE; Moretta L; Martelli MF; Grignani F; Mingari MC
    Blood; 1989 Oct; 74(5):1665-72. PubMed ID: 2506949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proliferation and cytolytic function of anti-CD3 + interleukin-2 stimulated peripheral blood mononuclear cells following bone marrow transplantation.
    Katsanis E; Anderson PM; Filipovich AH; Hasz DE; Rich ML; Loeffler CM; Ochoa AC; Weisdorf DJ
    Blood; 1991 Sep; 78(5):1286-91. PubMed ID: 1831682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukemic CD3+ LGL share functional properties with their CD8+ CD57+ cell counterpart expanded after BMT.
    Mollet L; Fautrel B; Leblond V; Bergeron F; Merle-Béral H; Baumelou E; Hubert P; Debré P; Autran B
    Leukemia; 1999 Feb; 13(2):230-40. PubMed ID: 10025897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coactivation with anti-CD28 monoclonal antibody enhances anti-CD3 monoclonal antibody-induced proliferation and IL-2 synthesis in T cells from autologous bone marrow transplant recipients.
    Lum LG; Joshi ID; Galoforo SC; Abella E; Karanes C; Ratanatharathorn V; Schultz KR; Uberti JP; Sensenbrenner LL; Ledbetter JA
    Bone Marrow Transplant; 1993 Dec; 12(6):565-71. PubMed ID: 8136739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA typing using IL-2 activated T lymphocytes: usefulness in pediatric candidates for allogeneic bone marrow transplantation.
    Kubo K; Tachino J; Ichikawa S; Hamamoto K; Ueda K
    Bone Marrow Transplant; 1991 Sep; 8(3):185-90. PubMed ID: 1720338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormally expanded CD8+/Leu-7+ lymphocytes persisting in long-term bone marrow-transplanted patients are resting pre-cytotoxic T-lymphocytes.
    Leroy E; Madariaga L; Ben Aribia M; Mishal Z; Theodorou I; Rochant H; Vernant JP; Senik A
    Exp Hematol; 1990 Aug; 18(7):770-4. PubMed ID: 1696205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of different protein kinase C-dependent events in T cells from allogeneic bone marrow transplantation recipients.
    Balboa MA; Izquierdo M; Sánchez-Madrid F; Fernández-Rañada JM; López-Botet M
    Clin Exp Immunol; 1992 Mar; 87(3):478-84. PubMed ID: 1544233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunodeficiency of bone marrow-transplanted patients. II. CD8-related suppression by patient lymphocytes of the response of donor lymphocytes to mitogens, antigens, and allogeneic cells.
    Odum N; Hofmann B; Jacobsen N; Langhoff E; Møller J; Platz P; Ryder LP; Svejgaard A
    Scand J Immunol; 1987 Sep; 26(3):247-53. PubMed ID: 2958929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Constitutive and mitogen-stimulated cytokine mRNA expression by peripheral blood mononuclear cells from most autologous and allogeneic bone marrow transplant recipients is intact.
    Lum LG; Joshi ID; Smith MR; Ratanatharathorn V; Galoforo SC; Karanes C; Uberti JP; Sensenbrenner LL
    Bone Marrow Transplant; 1994 Feb; 13(2):187-95. PubMed ID: 8205088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell ontogeny after autologous bone marrow transplantation: failure to synthesize interleukin-2 (IL-2) and lack of CD2- and CD3-mediated proliferation by both CD4- and CD8+ cells even in the presence of exogeneous IL-2.
    Cayeux S; Meuer S; Pezzutto A; Körbling M; Haas R; Schulz R; Dörken B
    Blood; 1989 Nov; 74(6):2270-7. PubMed ID: 2572284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8hi+CD57+ T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity.
    Mollet L; Sadat-Sowti B; Duntze J; Leblond V; Bergeron F; Calvez V; Katlama C; Debré P; Autran B
    Int Immunol; 1998 Mar; 10(3):311-23. PubMed ID: 9576619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD3+ CD57+ lymphocytes are not likely to be involved in antigen-specific rejection processes in long-term allograft recipients.
    Reipert B; Scheuch C; Lukowsky A; Reinke P; Fietze E; Döcke WD; Staffa G; Czerlinksi S; Hetzer R; Volk HD
    Clin Exp Immunol; 1992 Jul; 89(1):143-7. PubMed ID: 1378363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
    Klingemann HG; Kohn FR; Phillips GL
    Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of the CD8+CD57+ cell population in normal healthy individuals and matched unrelated T-cell-depleted bone marrow transplant recipients.
    Rowbottom AW; Garland RJ; Lepper MW; Kaneria SS; Goulden NJ; Oakhill A; Steward CG
    Br J Haematol; 2000 Aug; 110(2):315-21. PubMed ID: 10971387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by interleukin 4 of interleukin 2- or antibody-induced proliferation of lymphocytes from interleukin 2-treated cancer patients.
    Treisman J; Higuchi CM; Thompson JA; Gillis S; Lindgren CG; Kern DE; Ridell SR; Greenberg PD; Fefer A
    Cancer Res; 1990 Feb; 50(4):1160-4. PubMed ID: 2153452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.